tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
Company AnnouncementsCosmo Pharmaceuticals Enters Scale-Up Phase on Strong 2025 Results and AI, Dermatology Pipeline Momentum
2d ago
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
PremiumRatings
Cosmo Pharmaceuticals’ Breezula: A Promising Breakthrough in Hair-Loss Treatment with Significant Market Potential
1M ago
Cosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
PremiumCompany Announcements
Cosmo Pharmaceuticals Unveils Breakthrough Results for Male Hair Loss Treatment
1M ago
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
PremiumCompany Announcements
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in Brazil
2M ago
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
PremiumCompany Announcements
Cosmo Pharmaceuticals Advances in Sustainability with Enhanced ESG Rating and EcoVadis Recognition
2M ago
Cosmo Pharmaceuticals to Engage Investors at Key Conferences
PremiumCompany AnnouncementsCosmo Pharmaceuticals to Engage Investors at Key Conferences
2M ago
Cosmo Pharmaceuticals Secures CE Certification for ColonPRO EU, Expanding AI Colonoscopy Platform to Europe
Premium
Company Announcements
Cosmo Pharmaceuticals Secures CE Certification for ColonPRO EU, Expanding AI Colonoscopy Platform to Europe
2M ago
Cosmo Pharmaceuticals Secures EU Approval for Innovative Acne Treatment Winlevi®
Premium
Company Announcements
Cosmo Pharmaceuticals Secures EU Approval for Innovative Acne Treatment Winlevi®
3M ago
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in South Korea
PremiumCompany Announcements
Cosmo Pharmaceuticals Expands Global Reach with Winlevi® Approval in South Korea
3M ago
Cosmo Pharmaceuticals Gains CHMP Approval for Winlevi® in Europe
PremiumCompany Announcements
Cosmo Pharmaceuticals Gains CHMP Approval for Winlevi® in Europe
5M ago
Cosmo Pharmaceuticals Extends Global Supply Agreement with Takeda
PremiumCompany Announcements
Cosmo Pharmaceuticals Extends Global Supply Agreement with Takeda
5M ago
Cosmo Pharmaceuticals Unaffected by US Tariffs, Maintains Growth Momentum
PremiumCompany Announcements
Cosmo Pharmaceuticals Unaffected by US Tariffs, Maintains Growth Momentum
5M ago
Cosmo Pharmaceuticals Boosts 2025 EBITDA Guidance Amid Strong H1 Performance
PremiumCompany AnnouncementsCosmo Pharmaceuticals Boosts 2025 EBITDA Guidance Amid Strong H1 Performance
6M ago
Cosmo Pharmaceuticals Expands into Southeast Asia with Winlevi® Launch
Premium
Company Announcements
Cosmo Pharmaceuticals Expands into Southeast Asia with Winlevi® Launch
6M ago
Cosmo Pharmaceuticals Advances ESG Leadership with Key Initiatives
Premium
Company Announcements
Cosmo Pharmaceuticals Advances ESG Leadership with Key Initiatives
6M ago
Cosmo Pharmaceuticals Sets Bold 2030 Vision with AI-Driven Growth
PremiumCompany Announcements
Cosmo Pharmaceuticals Sets Bold 2030 Vision with AI-Driven Growth
7M ago
Cosmo Pharmaceuticals Sells ‘Digital Trust’ to Tinexta InfoCert
PremiumCompany Announcements
Cosmo Pharmaceuticals Sells ‘Digital Trust’ to Tinexta InfoCert
7M ago
Cosmo Pharmaceuticals Launches Pioneering Study Integrating AI with Apple Vision Pro
PremiumCompany Announcements
Cosmo Pharmaceuticals Launches Pioneering Study Integrating AI with Apple Vision Pro
7M ago
Cosmo Pharmaceuticals’ 2025 General Meeting Approves Dividend Increase
PremiumCompany Announcements
Cosmo Pharmaceuticals’ 2025 General Meeting Approves Dividend Increase
8M ago
Cosmo Pharmaceuticals Advances AI and GI Drug Development at DDW 2025
PremiumCompany AnnouncementsCosmo Pharmaceuticals Advances AI and GI Drug Development at DDW 2025
8M ago
Cosmo Pharmaceuticals’ AI-Powered Cerebro Receives EU-MDR Certification
Premium
Company Announcements
Cosmo Pharmaceuticals’ AI-Powered Cerebro Receives EU-MDR Certification
9M ago
Cosmo Pharmaceuticals Maintains 2025 Financial Forecast Amid CHMP Statement on Winlevi®
Premium
Company Announcements
Cosmo Pharmaceuticals Maintains 2025 Financial Forecast Amid CHMP Statement on Winlevi®
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >